Investigating the regulation of the senescence-associated secretory phenotype (S...
Investigating the regulation of the senescence-associated secretory phenotype (SASP) by mitochondrial DNA (mtDNA) metabolism for the development of novel senotherapies.
In response to various stresses such as DNA damage, telomere erosion, or oncogene activation, human cells can enter senescence. This process is characterized by irreversible proliferative arrest, deep transcriptional reprogramming...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ROOTS
Role of telomeres and stem cells in ageing
2M€
Cerrado
PGC2018-101927-B-I00
LAS CAUSAS EVOLUTIVAS Y MECANICAS DE LA SENESCENCIA Y SUS FE...
191K€
Cerrado
SAF2009-08605
IDENTIFICACION Y CARACTERIZACION DE GENES IMPLICADOS EN EL P...
151K€
Cerrado
SAF2015-65960-P
SENESCENCIA CELULAR: MECANISMOS DE REGULACION Y CONEXION CON...
190K€
Cerrado
TeloRNAging
The role of damage induced non coding RNA in the control of...
2M€
Cerrado
RTI2018-096859-B-I00
MODELOS MICROQUIMERICOS Y HERRAMIENTAS PARA EL ESTUDIO DE LA...
109K€
Cerrado
Información proyecto MitoDNASen
Duración del proyecto: 29 meses
Fecha Inicio: 2024-03-25
Fecha Fin: 2026-09-19
Líder del proyecto
UMEA UNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
207K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In response to various stresses such as DNA damage, telomere erosion, or oncogene activation, human cells can enter senescence. This process is characterized by irreversible proliferative arrest, deep transcriptional reprogramming, and expression of a collection of inflammatory factors termed the SASP (senescence-associated secretory phenotype). As it limits the proliferation of cells potentially bearing neoplastic potential, the triggering of cellular senescence is an essential tumor suppressing mechanism. However, the persistence and accumulation of senescent cells in aging and pathological contexts can have deleterious effects, particularly due to the SASP. It is thus fundamental to understand the basic physiology of senescent cells to develop so-called senomorphic drugs that modulate SASP expression. Changes in mitochondrial physiology elicited during cellular senescence onset strongly suggest that the maintenance and integrity of their mitochondrial DNA (mtDNA) may be altered. For instance, cytosolic leakage of mtDNA has been shown to take place in senescent cells and participate in SASP expression via immune pathways activation, but the contribution of mtDNA metabolism and replication in SASP expression has not yet been explored. My preliminary results show that mtDNA copy number increases continuously during senescence progression, accompanied by recomposing of the mitochondrial replisome. I also showed that this increase in mtDNA copy number promotes SASP expression. In the present project, I will characterize in details the alterations in mtDNA maintenance and integrity during senescence; profile the evolution of mitochondrial replisome composition; and characterize how the previous regulate SASP expression. The perspective of this project is to identify new senomorphic targets for controlling SASP expression and hereby alleviate the adverse effects of senescent cells in pathological contexts.